1. Home
  2. VYX vs OCS Comparison

VYX vs OCS Comparison

Compare VYX & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NCR Voyix Corporation

VYX

NCR Voyix Corporation

HOLD

Current Price

$6.56

Market Cap

1.6B

Sector

N/A

ML Signal

HOLD

Logo Oculis Holding AG Ordinary shares

OCS

Oculis Holding AG Ordinary shares

HOLD

Current Price

$25.03

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYX
OCS
Founded
1881
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VYX
OCS
Price
$6.56
$25.03
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
7
Target Price
$14.64
$41.86
AVG Volume (30 Days)
2.3M
372.9K
Earning Date
05-07-2026
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$466.06
Revenue Next Year
N/A
$502.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.46
$14.00
52 Week High
$14.67
$30.68

Technical Indicators

Market Signals
Indicator
VYX
OCS
Relative Strength Index (RSI) 30.82 38.36
Support Level $6.46 $19.00
Resistance Level $10.24 $29.19
Average True Range (ATR) 0.35 1.31
MACD -0.02 -0.39
Stochastic Oscillator 4.22 1.92

Price Performance

Historical Comparison
VYX
OCS

About VYX NCR Voyix Corporation

NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in three reportable segments: Retail, Restaurants, and Digital Banking. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The Digital Banking segment serves financial institutions with cloud-based software solutions for a fully integrated digital banking experience across channels. Revenue sources include software sales and service support within each segment.

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

Share on Social Networks: